Effectiveness of Rebound Therapy in Parkinson's Patients

NCT05855161 | Completed

• 1 other identifier: 5-PD-Rebound therapy-RCT
• Study Type: interventional
• Target: 17
• Locations: 1 country
• Sites: 1

Brief Summary

Today, physiotherapy approaches in Parkinson's Disease (PD) form the basis of optimal treatment together with medical and surgical treatment. It is stated that various rehabilitation interventions may be effective in the field of physiotherapy. The frequently preferred among these rehabilitation interventions is the conventional treatment approach. In the conventional treatment, various exercises are preferred to improve balance and walking, as well as stretching and strengthening. On the other hand, rebound therapy require strong integration of the neuromuscular system and provide more active use of lower extremity muscle strength. Rebound therapy have been shown to be effective in improving balance in many neurological disease groups, but there is very little study on rebound therapy in PD. It was shown that rebound therapy improve proprioceptive sense, joint range of motion and quality of life. On the other hand, no study has been found showing its effect on balance and walking. Therefore, there is a need to investigate the effectiveness of rebound therapy on balance and walking.

Conditions

Parkinson Disease

Keywords

Parkinson's disease; rebound therapy; task oriented training; balance and walking performance

Outcome Measures

Primary Outcomes (6)

• Static Balance- Baseline

  Assessment will be made with the Biodex Balance System

  Assessment will be conducted before the intervention

• Static Balance- Post intervention

  Assessment will be made with the Biodex Balance System

  Assessment will be conducted immediately after the intervention

• Gait speed- Baseline

  Assessment will be made with the BTS G-Walk, (BTS SpA, Via della Croce Rossa, 11 Padova, Italy; SN: 0213-0378) during gait

  Assessment will be conducted before the intervention

• Gait speed- Post intervention

  Assessment will be made with the BTS G-Walk, (BTS SpA, Via della Croce Rossa, 11 Padova, Italy; SN: 0213-0378) during gait

  Assessment will be conducted immediately after the intervention

• Knee strength- Baseline

  Assessment will be made with an isokinetic dynamometer (Cybex Humac Norm Testing and Rehabilitation System, CSMI, USA)

  Assessment will be conducted before the intervention

• Knee strength-Post intervention

  Assessment will be made with an isokinetic dynamometer (Cybex Humac Norm Testing and Rehabilitation System, CSMI, USA)

  Assessment will be conducted immediately after the intervention

Study Arms (2)

Rebound therapy

EXPERIMENTAL

The group that will perform exercises on a trampoline.

Other: Rebound therapy

Control group

EXPERIMENTAL

The group that will perform exercises on a stable surface.

Other: Exercises on a stable surface

Interventions

Rebound therapy OTHER

Participants will receive exercise-based training on a trampoline

Rebound therapy

Exercises on a stable surface OTHER

Participants will receive exercise-based training on a stable surface

Control group

Eligibility Criteria

• Age: 40 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• years of age
• Having diagnosed with "Parkinson's Disease" by a specialist physician
• Having between 1-3 stages according to the Hoehn and Yahr Scale
• Mini-Mental Test score more than or equal 24

You may not qualify if:

• \- Any orthopedic, vision, hearing, cardiovascular, or perception problems that may affect the research results

Sponsors & Collaborators

• Gazi University: lead

Study Sites (1)

Sivas Cumhuriyet University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

Sivas, Turkey (Türkiye)

Location

Related Publications (2)

• Daneshvar P, Ghasemi G, Zolaktaf V, Karimi MT. Comparison of the Effect of 8-Week Rebound Therapy-Based Exercise Program and Weight-Supported Exercises on the Range of Motion, Proprioception, and the Quality of Life in Patients with Parkinson's Disease. Int J Prev Med. 2019 Aug 12;10:131. doi: 10.4103/ijpvm.IJPVM_527_18. eCollection 2019.

  PMID: 31516672 BACKGROUND

• Eldemir S, Polat EA, Gokdogan CM, Eldemir K, Guclu-Gunduz A, Yilmaz R, Akbostanci MC, Yazici G. The effect of rebound therapy in Parkinson's disease: A single-blinded randomized controlled trial. Gait Posture. 2026 Jan 25;125:110105. doi: 10.1016/j.gaitpost.2026.110105. Online ahead of print.

  PMID: 41592453 DERIVED

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian Disorders; Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Model Details: Two groups as rebound group and control group

Study Record Dates

• First Submitted: May 3, 2023
• First Posted: May 11, 2023
• Study Start: April 10, 2023
• Primary Completion: November 10, 2023
• Study Completion: December 10, 2023
• Last Updated: December 28, 2023

Record last verified: 2023-12

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)